ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SKYA vs KRMD // 10Y YIELD & FRED MACRO BETA

SkyAI Inc. (NASDAQ) VS. KORU Medical Systems Inc. (NASDAQ) • 15-METRIC TALLY: SKYA 2 — KRMD 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SKYA VS. KRMD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SKYA KRMD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 62.30% -92.30 KRMD /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -28.70% -6.30 KRMD /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.67% 0.31% -8.98 KRMD /fcf-yield <GO>
Operating Margin -60.00% -7.20% -52.80 KRMD /operating-margins <GO>
Net Profit Margin -60.00% -6.40% -53.60 KRMD /net-margins <GO>
Revenue Growth (YoY) — 22.20% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 11.30 8.05 +3.25 SKYA /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 KRMD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 77.1 42.1 +35.04 SKYA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $126.7M $149.1M -$22.4M KRMD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SKYA REV KRMD REV SKYA GROSS % KRMD GROSS % SKYA FCF KRMD FCF
FY 2025 $204.1K $41.1M -50.0% 62.3% -$11.0M $462.4K
FY 2024 $0 $33.6M — 63.4% -$4.5M -$319.7K
FY 2023 $0 $28.5M — — -$8.5M -$4.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SKYA // BETA —
KRMD // BETA —